Intrathecal Double Checkpoint Inhibition
Intrathecal Double Checkpoint Inhibition
Active, not recruiting · NCT05598853 · Registry updated 2025-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intrathecal Double Checkpoint Inhibition | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neoplastic meningitis, nervous system disorder, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, tumor of meninges | Active, not recruiting | Phase 1 | 2025-10-02 | NCT05598853 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Zurich | 188 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospital Basel | Basel | Switzerland | 27 |
| University Hospital Geneva | Geneva | Switzerland | 9 |
| University Hospital Zurich | Zurich | Switzerland | 1 |